NearWave

Laboratory Equipment · Science & Engineering

Overview

What is Frequency Domain Near Infrared Spectroscopy (fdNIRS)?. In clinical applications, fdNIRS is used to measure optical properties such as absorption and scattering in deep tissue (1-2.5cm).

Funding and backers

Backers
5
Y Combinator, Health Wildcatters
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 5, 2023 Partnership NearWave Partners with the Lab of Prof.Dr.Ir. Nienke Bosschaart at the University of Twente · nearwave.co Jan 2022 Went through Y Combinator
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Daedal SystemsVenture round $4M · 1 mo ago · 11-50 employees
Industrialized plasma measurement systems for fusion reactors. Standardized diagnostics including Thomson scattering and spectroscopy on…
BrightSpecVenture round $3.9M · 18 mo ago · Founded 2012 · 51-200 employees
BrightSpec commercializes MRR spectroscopy instruments for definitive molecular structure identification and quantitation.
MantiSpectraVenture round $4.3M · 3 yr ago · 11-50 employees
A full near-infrared spectrometer on a 4×4 mm chip. Identify what things are made of in real time, without touching them.
pulsenics11-50 employees
Pulsenics AccelaGrade™. Accelerate QA/QC with Pulsenics' Rapid Electrochemical Impedance Spectroscopy Achieve faster, more reliable QA/QC…
Invisible-Light LabsPre-Seed · 5 mo ago · Founded 2019
ABOUT US We strive to make a positive impact on the world we live in by enabling groundbreaking scientific discoveries with EMILIE, the…
SchnaiTEC GmbH manufactures innovative research instruments that keeps you at the forefront of science. Our instruments include a…

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors5
9 portfolio companies: signalyzeai.com→, Amulis, Routora and 6 more
108 portfolio companies: MG Health Tech Inc., Patientx, Subqbionics and 105 more
VentureSouqVia a fund
265 portfolio companies: Zoomcar, Zippi, Horizen Labs and 262 more
325 portfolio companies: Zorion Medical, Fashion Labs, Mykala and 322 more
Y CombinatorVia a fund
6310 portfolio companies
Show all 5

News

News ycombinator 2 years ago
Launch YC: NearWave - Realtime therapy efficacy for treating breast cancer patients Y Combinator
NearWave makes a new type of handheld imaging tech with AI that helps physicians select the right therapy for their breast cancer patients.
Read more
Report
Blog 2 years ago
Check out NearWave on Launch YC!
NearWave has launched! Check us out on Launch YC along with other great YC startups and be sure to give us an upvote before you go! In other news, we just submitted our Pre-Submission to the FDA and received a letter that the FDA agrees with our regulator
Read more
Report
Award YahooFinance 3 years ago
Notre Dame start-up Nearwavewins annual commercialization award
Nearwave, a Notre Dame medical device maker, came away with the top prize recently in the annual 1st Source Bank Commercialization Award competition.
Read more
Report
Award 3 years ago
NearWave Co-founder Wins First Place in 1st Source Bank Commercialization Awards
We are happy to announce that NearWave co-founder Thomas O'Sullivan was awarded first place in 1st Source Bank's 2023 Commercialization Awards. The Commercialization Award is presented annually to faculty from the University of Notre Dame or the Indiana U
Read more
Report
Blog 3 years ago
NearWave Wins PitchForce Competition
We are happy to announce that NearWave was awarded first place in PitchForce's Life Science pitch competition! PitchForce connects startups with VC and angel investors for valuable feedback and investment opportunities.
Read more
Report
Blog 3 years ago
NearWave Receives Investment from Cancer Fund Impact Investments
Cancer Fund Impact Investments has invested in NearWave. We are grateful for the support of their team! See Cancer Fund's Investment
Read more
Report
Award 3 years ago
NearWave Receives Patent Award from the EU
We are happy to announce that our frequency domain diffuse optical spectroscopy technology and optical detector calibration method has been awarded a patent by the European Patent Organization! See Patent
Read more
Report
Blog 3 years ago
NearWave Invited to Present at ECBO23 European Conferences on Biomedical Optics
NearWave founder and CEO, Roy Stillwell, had the honor of speaking at the European Conferences on Biomedical Optics on NearWave Imager: the first entirely handheld real-time frequency-domain near-infrared spectroscopy imaging system. See Publication
Read more
Report
Blog 3 years ago
NearWave Founder Gives 'Hot Topics' Talk at ECBO Conference
NearWave Founder Dr. Thomas O'Sullivan was invited to speak on Diffuse Optical Spectroscopy and Imaging at the European Conference on Biomedical Optics, where he served as Conference Chair. See Publication
Read more
Report
Blog 3 years ago
NearWave Attends TechConnect World 2023 Conference
NearWave had the pleasure of presenting at the TechConnect World Innovation Conference & Expo for Innovations in Precision Health and Diagnostics for Health Wellness. See TechConnect 2023 Program
Read more
Report
Show more news

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Austin United States
HQ